Zybio

Zybio (中元汇吉生物技术股份有限公司) is a Chinese in-vitro diagnostics (IVD) company whose product portfolio spans most major clinical laboratory disciplines. According to its official website, the company offers instruments and reagents for microbiology, molecular diagnostics, chemiluminescence immunoassay (CLIA), clinical chemistry, point-of-care testing (POCT), hemostasis/coagulation, hematology, urinalysis, and veterinary diagnostics. This breadth positions Zybio as a full-line IVD supplier serving hospitals, clinical laboratories, and veterinary clinics. Zybio's product lines include named instrument families such as the EXS 2600, EXS 3000, and EXB 120 for microbiology; the EXM 6000 and EXM 3000 for molecular diagnostics, along with extraction kits, detection kits, VTM, ZIP-96V, and EXP 160; the EXI 1800, EXI 2400, and EXI 1820 chemiluminescence analyzers with associated reagents; the EXC 200, EXC 400, and EXC 460 clinical chemistry analyzers; POCT offerings including SARS-CoV-2 and Q8 Pro, EXR110/120, and MxA; hemostasis systems EXT 4800, EXT 3800, YX-3000, and YX-2000 with coagulation reagents; hematology analyzers in the Z3, Z3 CRP, Z50, EXZ 6000, and EXZ 8000 series with hematology reagents; urinalysis systems U3600 and U1600/U2610; and veterinary products including EXM3000, EXM6000, EXP160, EXP960, nucleic acid extraction and qPCR detection kits, Z4 VET, and Z52 VET. The company presents itself as an innovative R&D-based organization, with website sections dedicated to About Us, Our Honor, Corporate Culture, Milestone, and News. Its official site is available in English, Simplified Chinese, Russian, Spanish, and French, indicating an international commercial orientation beyond its home market. Zybio maintains a presence on Wikidata (Q116180791). Specific details such as founding year, founders, ownership structure, and listing status are not established by the available evidence and are therefore omitted here. The company is active and continues to market a broad IVD portfolio.

Zybio (中元汇吉生物技术股份有限公司) is a Chinese in-vitro diagnostics company. The available evidence from its official website and Wikidata does not establish a founding date, founders, or a detailed corporate chronology. What can be documented is the company's current product architecture and market posture. Zybio presents itself as an R&D-based IVD manufacturer. Its website organizes products into major clinical laboratory segments: Microbiology, Molecular, CLIA (chemiluminescence immunoassay), Clinical Chemistry, POCT, Hemostasis, Hematology, Urinalysis, and VET (veterinary). Within each segment, the company markets both analyzers and the consumable reagents that run on them, a common full-line strategy among IVD suppliers. In microbiology, Zybio lists the EXS 2600, EXS 3000, and EXB 120 instruments together with microbiology reagents. In molecular diagnostics, it offers the EXM 6000 and EXM 3000 systems, extraction kits, detection kits, VTM, ZIP-96V, and EXP 160. Its chemiluminescence line includes the EXI 1800, EXI 2400, and EXI 1820 analyzers with chemiluminescence reagents. Clinical chemistry is served by the EXC 200, EXC 400, and EXC 460 analyzers and chemistry reagents. POCT products include SARS-CoV-2 tests, Q8 Pro, EXR110/120, and MxA. Hemostasis products include the EXT 4800, EXT 3800, YX-3000, and YX-2000 systems with coagulation reagents. Hematology includes the Z3 series, Z3 CRP series, Z50 series, EXZ 6000 series, and EXZ 8000 series with hematology reagents. Urinalysis includes the U3600 and U1600/U2610. The veterinary line includes EXM3000, EXM6000, EXP160, EXP960, nucleic acid extraction kits, nucleic acid qPCR detection kits, Z4 VET, and Z52 VET. The company's website is multilingual—English, Simplified Chinese, Russian, Spanish, and French—suggesting an export-oriented commercial strategy. Website sections such as About Us, Our Honor, Corporate Culture, Milestone, and News indicate that the company maintains a public corporate narrative, though the specific milestone dates are not captured in the supplied evidence. Zybio has a Wikidata entry (Q116180791). Because the evidence does not provide founding year, ownership, or listing details, this history remains incomplete and should be expanded if authoritative sources become available.

Full-line in-vitro diagnostics (IVD) supplier with an innovative R&D focus, serving clinical laboratories and veterinary markets internationally.

• EXS 2600

• EXS 3000

• EXB 120

• EXM 6000

• EXM 3000

• EXI 1800

• EXI 2400

• EXI 1820

• EXC 200

• EXC 400

• EXC 460

• Q8 Pro

• EXR110/120

• MxA

• EXT 4800

• EXT 3800

• YX-3000

• YX-2000

• Z3 Series

• Z3 CRP Series

• Z50 Series

• EXZ 6000 Series

• EXZ 8000 Series

• U3600

1. 1Zybio official websitezybio.com
2. 2Zybio About Uszybio.com
3. 3Zybio Productszybio.com
4. 4Zybio Corporate Culturezybio.com
5. 5Wikidata entry for 中元汇吉生物技wikidata.org